Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes
2012
Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.
1988
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Stellate Cell Activation in Alcoholic Pancreatitis
2003
Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature
2008
Epidemiology of pancreatic cancer: an overview
2009
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
2012 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Pancreatic cancer
2004 Standout
Role of Organochlorine Compounds in the Etiology of Pancreatic Cancer: A Proposal to Develop Methodological Standards
2001
Clinical Outcome Following Treatment of Refractory Inflammatory and Fistulizing Crohn's Disease With Intravenous Cyclosporine
1998
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
Angiotensin II Mediates Acinar Cell Apoptosis During the Development of Rat Pancreatic Fibrosis by AT1R
2004
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Cystic fibrosis
2016 Standout
Pancreatic cancer
2020 Standout
Epidemiologic and etiologic factors of pancreatic cancer
2002
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Delivery materials for siRNA therapeutics
2013 Standout
Pancreatic cancer
2016 Standout
Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis
2010
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
2011
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma
2009
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Pancreatic cancer mortality and organochlorine pesticide exposure in California, 1989–1996
2003
Pancreatic Adenocarcinoma
2014 Standout
Adverse Drug Events Related to Dosage Forms and Delivery Systems
1996
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer
2002
Inflammatory Bowel Disease
1991 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer
2002
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Intestinal mucosal barrier function in health and disease
2009 Standout
Organochlorines and Risk of Prostate Cancer
2003
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
2011
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
2014
IAP Guidelines for the Surgical Management of Acute Pancreatitis
2002
Tobacco and the risk of pancreatic cancer: a review and meta-analysis
2008
Ulcerative colitis
2016 Standout
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
2006 Standout
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
2001
Occupational exposure to pesticides and pancreatic cancer
2001
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pancreatic Cancer
2010 Standout
Genetic Polymorphisms in Alcoholic Pancreatitis
2005
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
2021
Early detection of pancreatic cancer
2020
Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice
2008
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Interleukin-10 Gene-Deficient Mice Develop a Primary Intestinal Permeability Defect in Response to Enteric Microflora
1999
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Genetics and biology of pancreatic ductal adenocarcinoma
2006
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Pancreatic cancer
2011 Standout
Association with Selected Bacteria Does Not Cause Enterocolitis in IL-10 Gene-Deficient Mice Despite a Systemic Immune Response
2005
Proteomics biomarkers for solid tumors: Current status and future prospects
2018
Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer
2004
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Risk of pancreatic cancer and occupational exposures in Spain
2000
Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
2000
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
2000
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
IAP Guidelines for the surgical management of acute pancreatitis
2002
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Health impacts of pesticide exposure in a cohort of outdoor workers.
2002
Works of Luisa Guarner being referenced
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
2015
Pancreatic cancer risk and levels of trace elements
2011
Learning from Case Reports
1998
Intravenous Cyclosporine for Steroid-Refractory Attacks of Crohnʼs Disease
1995
Lifetime history of alcohol consumption and K‐ras mutations in pancreatic ductal adenocarcinoma
2009
Gastrointestinal, Liver, and Pancreatic Involvement in Adult Patients with Cystic Fibrosis
2001
Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage
2005
Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
1999
Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology
2000
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer
2007
Occupation and pancreatic cancer in Spain: a case-control study based on job titles
2000
Induction of Chronic Pancreatic Disease by Trinitrobenzene Sulfonic Acid Infusion into Rat Pancreatic Ducts
1996
Efficacy of Intravenous Cyclosporine for Steroid Refractory Attacks of Ulcerative Colitis
1995
Cystic fibrosis transmembrane regulator ( CFTR ) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer
2001
Fate of oral enzymes in pancreatic insufficiency.
1993
Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease.
1986
Acute necrotizing pancreatitis: a multicenter study.
1994
1999
Phenotypic variability in a Spanish family with MNGIE
2002
Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
1999